Novozymes Bioag A/S
USPTO PatentsView assignee record - 48 granted patents across 17 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators).
The verdict
According to USPTO PatentsView, Novozymes ranks #6,934 of 49,997 tracked US assignees by granted-patent volume, with 48 patents across 17 technology areas.
- #6,934
- of 49,997 US assignees by volume
- Top 18%
- by Innovation Score (47.6/100)
- 20.8
- avg claims per patent
- -17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6934 · Foreign Corporation #6,934 · 48 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
- GRANTS-SMALL 48 grants
- UPPER-Q #6,934/49,997
- PHOTO-FINISH Naver Labs
- CPC-FOCUS A01N · 17 areas
- INNOV-PAR 47.6/100
- CLAIMS-DENSE 20.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DOWN -17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Naver Labs Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Novozymes’s 47.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Novozymes
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Humax · near
Humax · near
48 score
- Liebherr-werk Nenzing · near
Liebherr-werk Nenzing · near
48 score
- Novozymes Bioag A/S · this assignee
Novozymes Bioag A/S · this assignee
48 score
- RealD · near
RealD · near
48 score
- Yazaki North America · near
Yazaki North America · near
48 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Novozymes's Innovation Score is 47.6/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Novozymes?
Each dot is one of Novozymes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novozymes’s own 20.8 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Novozymes's grants concentrate
Novozymes Bioag A/S is a focused PatentsView assignee: 17 CPC subclasses with 91.7% of grants classified under A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators). Peak complete grant year is 2019 (7 grants) versus a trough of 2 in 2018. By volume, Novozymes sits between Naver Labs Corporation and Neuroderm, Ltd..
Novozymes's three-year grant acceleration
Novozymes Bioag A/S shows 14 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Novozymes's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Naver Labs
Naver Labs Corporation
48 patents
- Nippon Chemical I…
Nippon Chemical Industrial Co., Ltd.
48 patents
- Nippon Micrometal
Nippon Micrometal Corporation
48 patents
- Noblis
Noblis, Inc.
48 patents
- Neapco Intellectu…
Neapco Intellectual Property Holdings, LLC
48 patents
- Netsia
Netsia, Inc.
48 patents
- Netsuite
Netsuite Inc.
48 patents
- Neuroderm
Neuroderm, Ltd.
48 patents
- Novozymes Bioag A… ◀
Novozymes Bioag A/S
48 patents
What this shows Novozymes holds 48 patents at rank #6,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Novozymes
By rank, the assignees closest to #6,928 in granted patent volume.
- Naver Labs Corporation #6,924 · 48 patents
- Nippon Chemical Industrial Co., Ltd. #6,925 · 48 patents
- Nippon Micrometal Corporation #6,926 · 48 patents
- Noblis, Inc. #6,927 · 48 patents
- Neapco Intellectual Property Holdings, LLC #6,929 · 48 patents
- Netsia, Inc. #6,930 · 48 patents
- Netsuite Inc. #6,931 · 48 patents
- Neuroderm, Ltd. #6,932 · 48 patents
Leaders in A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…)
Other assignees with the most granted patents in Novozymes's primary technology class.
- Basf SE 420 in class
- Syngenta Participations AG 393 in class
- Bayer Cropscience Aktiengesellschaft 378 in class
- DOW Agrosciences LLC 360 in class
- Sumitomo Chemical Company, Limited 306 in class
- Monsanto Technology LLC 284 in class
- Ecolab USA Inc. 230 in class
- Bayer Intellectual Property GmbH 202 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Novozymes, neither rank-band nor same-CPC leaders (those blocks stay above). In A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR…), Novozymes ranks #29 of 1,216 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (48 here).
Novozymes's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
48 Top 18% higher than 82% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 12.5% |
| 2016 | 5 | 10.4% |
| 2017 | 4 | 8.3% |
| 2018 | 2 | 4.2% |
| 2019 | 7 | 14.6% |
| 2020 | 3 | 6.3% |
| 2021 | 3 | 6.3% |
| 2022 | 4 | 8.3% |
| 2023 | 5 | 10.4% |
| 2024 | 5 | 10.4% |
| 2025partial year | 4 | 8.3% |
Which technologies does Novozymes Bioag A/S patent most?
Top 15 of 17 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Novozymes Bioag A/S's patent record in context - here's where to go next.
- Novozymes Bioag A/S's lead technology class is A01N (Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators), 91.7% of its portfolio - see every assignee active in that class. Explore A01N
- Ranked #6,934 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Novozymes Bioag A/S against Naver Labs Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 47.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.